Comparable Clinical Effectiveness of Baricitinib and Filgotinib in Patients With Rheumatoid Arthritis

20250 citationsJournal Articlebronze Open Access

Authors

Hironobu Kosugiyama · Nagoya University

Shuji Asai · Nagoya University

Kenya Terabe · Nagoya University

Tomonori Kobayakawa

Yutaka Yoshioka · Handa City Hospital

Tatsuo Watanabe · Daido University

Toshihisa Kojima · Nagoya Medical Center

Abstract

Baricitinib and filgotinib demonstrated comparable drug retention rates and effectiveness in reducing disease activity among patients with RA over a 24-week follow-up period.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Rheumatic Diseases

Volume 28, Issue 5, pp. e70288-e70288

DOI: 10.1111/1756-185x.70288

Field-Weighted Citation Impact: 0.00